U.S. Patent and Trademark Office (USPTO) Director John Squires is reportedly exceeding his granted powers under the America Invents Act (AIA) by exercising too much discretion in denying patent challenges. This assertion comes from Representative Darrell Issa, a key figure in intellectual property within the U.S. House of Representatives. According to Issa, the Patent Trial and Appeal Board (PTAB) was never meant to have its discretionary powers interpreted as “100% discretionary,” challenging the broad authority currently exercised by Squires.
This criticism highlights ongoing debates surrounding the scope and application of discretionary denial powers at PTAB, an issue that has long simmered within patent law circles. As noted by Law360, Rep. Issa contends that Squires’ actions deviate from Congress’s intent, as outlined when the AIA was enacted. This intent, according to Issa, is to permit discretion but within defined boundaries, ensuring that PTAB remains a venue for fair and judicious review of patent claims.
Critics of broad discretionary use argue that it undermines the PTAB’s role, potentially leaving substantial patentability questions unresolved, and thus affecting innovation incentives. Supporters, however, contend that discretion can manage the PTAB’s caseload effectively and deter frivolous or strategically motivated challenges. As such, the issue brings into sharp focus the balance between efficiency and fairness in patent adjudication.
The debate over PTAB’s discretion is not new. Prior instances, such as the precedent set in 2020 regarding follow-on petitions and parallel litigation, highlight persistent tensions about the extent and appropriateness of discretion. Stakeholders continue to watch closely as these interpretations have far-reaching implications not only for patent holders and challengers but for the broader landscape of U.S. innovation and technology development.